Metropolitan Life Insurance CO Replimune Group, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $6,176 - $8,583	387 Added 17.36%	2,616 $44,000
Q2 2023 Aug 10, 2023	SELL	$15.65 - $24.1 $4,679 - $7,205	-299 Reduced 11.83%	2,229 $51,000
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $1,328 - $2,210	76 Added 3.1%	2,528 $44,000
Q4 2022 Jun 14, 2023	SELL	$17.09 - $27.91 $1,298 - $2,121	-76 Reduced 3.01%	2,452 $66.7 Million
Q3 2022 Jun 14, 2023	SELL	$15.6 - $21.15 $1,185 - $1,607	-76 Reduced 3.01%	2,452 $42.3 Million
Q3 2022 Mar 30, 2023	BUY	$15.6 - $21.15 $11,138 - $15,101	714 Added 41.08%	2,452 $42,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $11,138 - $15,101	714 Added 41.08%	2,452 $42,000
Q2 2022 Jun 20, 2023	SELL	$13.32 - $19.98 $10,522 - $15,784	-790 Reduced 31.25%	1,738 $30,000
Q1 2022 Jun 20, 2023	SELL	$15.24 - $29.75 $12,039 - $23,502	-790 Reduced 31.25%	1,738 $29,000
Q1 2022 Mar 30, 2023	SELL	$15.24 - $29.75 $81,442 - $158,984	-5,344 Reduced 75.46%	1,738 $29,000
Q1 2022 May 12, 2022	SELL	$15.24 - $29.75 $81,442 - $158,984	-5,344 Reduced 75.46%	1,738 $30,000
Q4 2021 Jun 21, 2023	BUY	$25.43 - $34.25 $115,808 - $155,974	4,554 Added 180.14%	7,082 $191,000
Q3 2021 Jun 21, 2023	BUY	$28.98 - $39.54 $131,974 - $180,065	4,554 Added 180.14%	7,082 $209,000
Q2 2021 Jun 21, 2023	BUY	$28.5 - $39.37 $129,789 - $179,290	4,554 Added 180.14%	7,082 $272,000
Q2 2021 Mar 30, 2023	BUY	$28.5 - $39.37 $10,174 - $14,055	357 Added 5.31%	7,082 $272,000
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $201,637 - $278,542	7,075 Added 101071.43%	7,082 $272,000
Q1 2021 Jun 26, 2023	BUY	$30.22 - $45.57 $126,833 - $191,257	4,197 Added 166.02%	6,725 $205 Million
Q1 2021 May 14, 2021	SELL	$30.22 - $45.57 $203,017 - $306,139	-6,718 Reduced 99.9%	7 $205,000
Q4 2020 Jun 22, 2023	BUY	$23.5 - $52.65 $98,629 - $220,972	4,197 Added 166.02%	6,725 $256,000
Q3 2020 Jun 26, 2023	BUY	$18.85 - $27.0 $79,113 - $113,319	4,197 Added 166.02%	6,725 $154,000
Q3 2020 Mar 30, 2023	BUY	$18.85 - $27.0 $6,899 - $9,882	366 Added 5.76%	6,725 $154,000
Q3 2020 Nov 13, 2020	BUY	$18.85 - $27.0 $6,899 - $9,882	366 Added 5.76%	6,725 $155,000
Q2 2020 Jun 26, 2023	BUY	$9.76 - $25.95 $37,390 - $99,414	3,831 Added 151.54%	6,359 $158,000
Q2 2020 Mar 30, 2023	BUY	$9.76 - $25.95 $38,132 - $101,386	3,907 Added 159.34%	6,359 $158,000
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $62,063 - $165,016	6,359 New	6,359 $158,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$156 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$139 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$68.5 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$67.3 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$66.4 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account